Breast Cancer, Vaccine

A Clinical Trial Found an Effective Vaccine for Aggressive Breast Cancer
An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.
Wash U vaccine trial shows promising data in preventing breast cancer recurrence
A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a new vaccine that is preventing cancer from returning.
New vaccine shows promise for patients with aggressive breast cancer
An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.
New Therapeutic Vaccine Gives Hope Against an Aggressive Breast Cancer
We acknowledge the limitations of this type of analysis, but we are continuing to pursue this vaccine strategy and have ongoing randomized controlled trials that do make a dire
Breast cancer hope as vaccine shows “promising” results
Breast cancer patients have been given fresh hope after a new vaccine showed “promise” in treating an aggressive form of the disease. The results came in a clinical trial involving American patients with triple-negative breast cancer who received an experimental jab designed to prevent the recurrence of tumours.
The Brighterside of News on MSN4d
Anti-cancer drug shows incredible promise in human clinical trials
For decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...
GlobalData on MSN10h
Kronos mulls ‘strategic alternatives’ after axing cancer drug development
The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...
LancasterOnline11h
Q&A: New top doctor aims to bring more clinical trials to Ann B. Barshinger Cancer Institute
More clinical trials offering cutting-edge cancer care in Lancaster County will be among the changes if Dr. Efrat Dotan meets ...
News Medical on MSN2h
New drug strategy reverses resistance to immunotherapy in pancreatic cancer
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...
Becker's Hospital Review1d
Meet the group making cancer trials more equitable in Minnesota
Marie Rahne, director, and Douglas Yee, MD, interim medical director of the Minnesota Cancer Clinical Trial Network spoke to Becker's about how their organization is broadening the scope of cancer ...
UVA Today2d
Q&A: What’s Going on With Lung Cancer Research?
Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...
Impacts16h
Ivermectin for Cancer in Humans: Understanding the Dosage and Potential Benefits
Ivermectin is an antiparasitic agent, and its potential as an anticancer agent has recently attracted increasing attention.
7,000 volunteers help Southampton study aiming to diagnose lung cancer earlier
More than 7,000 Hampshire people have helped Southampton scientists with a ground-breaking study to find new ways to diagnose ...
Cell therapy fights lethal childhood brain cancer in clinical trial
An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...
FOX 475h
Local doctor shares challenges and innovations of treating prostate cancer
Prostate cancer affects men all over the world and cutting edge research and clinical trials are happening right here in Madison. As part of our effort to raise ...